CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI)

CUSIP: 163572209

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COM NEW
Total 13F shares
6,965,342
Share change
-1,389,734
Total reported value
$24,452,323
Put/Call ratio
148%
Price per share
$3.51
Number of holders
69
Value change
-$6,034,981
Number of buys
24
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP 163572209?
CUSIP 163572209 identifies CEMI - CHEMBIO DIAGNOSTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) as of Q1 2021

As of 31 Mar 2021, CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) was held by 69 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,965,342 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, SEGALL BRYANT & HAMILL, LLC, ROYCE & ASSOCIATES LP, Penbrook Management LLC, GEODE CAPITAL MANAGEMENT, LLC, PERKINS CAPITAL MANAGEMENT INC, STATE STREET CORP, NORTHERN TRUST CORP, and Ikarian Capital, LLC. This page lists 69 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.